Throughout Africa, Project HOPE addresses pressing health challenges aiming to reduce maternal and child mortality and the burdens of HIV/AIDS, TB, diabetes and hypertension.
Project HOPE in Africa
What's New in Africa
World AIDS Day: HOPE in Namibia
On this World AIDS Day, I am feeling very inspired by colleagues in the fight against HIV/AIDS in Namibia, the same country where I first decided to join the fight quite a few years ago.
How HOPE Helps Others
One Day at a Time
In my first 12 months as HOPE’s new President and CEO, I’ve been privileged to visit colleagues in 13 countries in Africa, Asia and Latin America.
AIDS: We Must Not Forget
The world’s top HIV/AIDS experts are gathering in Durban, South Africa for the 21st International AIDS Conference - a meeting that fills me with hope that an opportunity is at hand to finally get the disease under control, but it’s an opportunity that is tempered with a little caution.
The Global Fight Against a Potent Killer
A century-and-a-half ago tuberculosis (TB) was such a fact of daily life that the tragic romance of a young woman dying from the disease was immortalized in Giuseppe Verdi’s famous opera La Traviata. No one is writing operas, or their modern equivalent, movies or television shows about TB these days, and most people probably never give it a second thought — even though it is a disease that has afflicted the likes of celebrities like Nelson Mandela, Ringo Star, Sir Tom Jones and Tina Turner.
Replacing Despair with Promise
When Martha Ziezo, a community home based care provider, met Wabei, she found a woman who felt helpless and stigmatized.
New Treatment Regimen Brings Hope for MDR-TB Patients
Hundreds of thousands of patients with multidrug resistant tuberculosis (MDR-TB), a form of TB infection caused by bacteria that are resistant to powerful drugs used to cure the disease, suddenly have reason to hope. The World Health Organization (WHO) has just cleared a new shortened treatment regimen for multidrug-resistant tuberculosis (MDR-TB) which carries grave risks for nearly half a million people who developed a condition that killed 190,000 people in 2014.